Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for BCRP with Rosuvastatin and Eltrombopag
NCT04542382Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of eltrombopag in Thrombocytopenia, sponsored by University of California, San Francisco. Primary endpoint: Composite of pharmacokinetics of co-administration of rosuvastatin and eltrombopag at 72 hours. Started Oct 2021; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT04542382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542382.